Hepatic safety and antiretroviral effectiveness in HIV-infected patients receiving naltrexone. [electronic resource]
Producer: 20120517Description: 318-24 p. digitalISSN:- 1530-0277
- Adult
- Aged
- Alanine Transaminase -- blood
- Alcoholism -- complications
- Antiretroviral Therapy, Highly Active -- adverse effects
- Aspartate Aminotransferases -- blood
- CD4 Lymphocyte Count
- Chemical and Drug Induced Liver Injury -- epidemiology
- Cohort Studies
- Databases, Factual
- Drug Interactions
- Drug-Related Side Effects and Adverse Reactions
- Female
- HIV Infections -- complications
- Humans
- Liver -- enzymology
- Liver Function Tests
- Male
- Middle Aged
- Naltrexone -- adverse effects
- Narcotic Antagonists -- adverse effects
- Opioid-Related Disorders -- complications
- RNA, Viral -- blood
- Veterans
No physical items for this record
Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, U.S. Gov't, Non-P.H.S.
There are no comments on this title.
Log in to your account to post a comment.